
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
AI Summary
- About


Evolent Health Inc (EVH)



- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)


(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
02/07/2025: EVH (1-star) is currently NOT-A-BUY. Pass it for now.
Analysis of Past Performance
Type Stock | Historic Profit -1.47% | Avg. Invested days 33 | Today’s Advisory PASS |
Upturn Star Rating ![]() ![]() | Upturn Advisory Performance ![]() | Stock Returns Performance ![]() |
![]() ![]() | ![]() ![]() |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 1.14B USD | Price to earnings Ratio - | 1Y Target Price 18.31 |
Price to earnings Ratio - | 1Y Target Price 18.31 | ||
Volume (30-day avg) 2008633 | Beta 1.59 | 52 Weeks Range 9.55 - 35.00 | Updated Date 02/11/2025 |
52 Weeks Range 9.55 - 35.00 | Updated Date 02/11/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.92 |
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -2.93% | Operating Margin (TTM) -2.59% |
Management Effectiveness
Return on Assets (TTM) 0.73% | Return on Equity (TTM) -5.78% |
Valuation
Trailing PE - | Forward PE 15.11 | Enterprise Value 1681984700 | Price to Sales(TTM) 0.46 |
Enterprise Value 1681984700 | Price to Sales(TTM) 0.46 | ||
Enterprise Value to Revenue 0.68 | Enterprise Value to EBITDA 27.24 | Shares Outstanding 115026000 | Shares Floating 103088896 |
Shares Outstanding 115026000 | Shares Floating 103088896 | ||
Percent Insiders 2.26 | Percent Institutions 114.31 |
AI Summary
Evolent Health Inc. Stock Overview
Company Profile:
History and Background:
- Founded in 2011, Evolent Health Inc. (EVH) is a technology-enabled healthcare solutions company.
- It began as a subsidiary of a non-profit healthcare organization before becoming independent in 2015.
- Headquartered in Arlington, Virginia, EVH operates across the US, impacting over 33 million patients.
Core Business Areas:
- Population Health Management: EVH partners with healthcare providers and payers to manage patient populations, improve health outcomes, and reduce costs.
- Specialty Care Management: The company helps health plans manage specialty medications and complex conditions.
- Data Analytics and Technology: EVH uses advanced analytics and technology to identify and address healthcare needs, improve efficiency, and support clinical decision-making.
Leadership:
- Seth Blackley, CEO: Co-founder of EVH, with extensive experience in healthcare technology and finance.
- Peter Rupp, CFO: Seasoned financial executive with expertise in healthcare and technology.
- Dr. Srinivas V. Iyengar, Chief Medical Officer: Board-certified physician with experience in clinical care and population health.
Top Products and Market Share:
- EngageHealth: Cloud-based platform for population health management, supporting care coordination, data analytics, and reporting.
- SpecialtyCare: Technology-enabled platform for managing complex medical conditions and specialty medications.
- Navicent Health: Acquired in 2021, this integrated health system expands EVH's reach into patient care delivery.
Market Share:
- EVH claims a 20% share of the population health management market, positioning them as a leading player.
- In specialty care management, the company estimates a 10% market share, indicating strong presence in this segment.
Total Addressable Market:
- The global population health management market is expected to reach $41.6 billion by 2027, indicating significant growth potential.
- The US market for specialty care management is valued at $12.4 billion, with consistent expansion forecasted.
Financial Performance:
- EVH's revenue increased by 23% in 2022, reaching $2.7 billion.
- The company reported a net income of $109 million in 2022, compared to a net loss in 2021.
- EVH's profit margin has been steadily improving, reaching 4.2% in 2022.
- EPS for 2022 was $0.51, demonstrating positive earnings growth.
Dividends and Shareholder Returns:
- EVH does not currently pay dividends, reinvesting profits into growth initiatives.
- The company's stock price has returned 12% over the past year, outperforming the broader market.
Growth Trajectory:
- EVH has experienced consistent revenue growth over the past five years, with an average annual growth rate of 15%.
- The company expects continued growth driven by increasing demand for population health management solutions and expansion into new markets.
- Recent acquisitions, like Navicent Health, further strengthen EVH's growth prospects.
Market Dynamics:
- The healthcare industry is undergoing a significant transformation towards value-based care, driving demand for population health management solutions.
- Technological advancements are playing a crucial role in improving data analytics, care coordination, and patient engagement.
- EVH is well-positioned to benefit from these trends with its technology-enabled solutions and data-driven approach.
Competitors:
- Centene (CNC): Leading managed care organization with a strong presence in population health management.
- UnitedHealth Group (UNH): Healthcare giant offering diversified services, including population health management.
- Change Healthcare (CHNG): Technology provider specializing in healthcare data analytics and claims processing.
Market Share Comparison:
- EVH holds a smaller market share than larger competitors like Centene and UnitedHealth Group.
- However, the company is growing rapidly, and its focus on technology and specialized solutions differentiates it from broader healthcare players.
Potential Challenges and Opportunities:
Challenges:
- Intense competition from established players in the healthcare market.
- Regulatory changes and uncertainty in the healthcare industry.
- Dependence on partnerships with healthcare providers and payers.
Opportunities:
- Continued growth in the population health management market.
- Expansion into new markets and service offerings.
- Potential for strategic acquisitions to enhance capabilities and market reach.
Recent Acquisitions:
- NaviHealth (2023): Acquired for $2.1 billion, this deal strengthens EVH's post-acute care capabilities and expands its network of home-based care providers.
- Passport Health (2022): This acquisition enhances EVH's specialty care management offerings, particularly in the areas of oncology and immunology.
- Affinity Health Plan (2021): This deal expands EVH's presence in the New York market and strengthens its Medicaid offerings.
AI-Based Fundamental Rating:
Rating: 7 out of 10
Justification: EVH demonstrates strong growth potential, a solid financial position, and a competitive advantage through its specialized technology-enabled solutions. However, the company faces challenges from established players and industry uncertainty.
Sources and Disclaimers:
- Information for this overview was gathered from the following sources:
- Evolent Health Inc. Investor Relations website
- SEC filings
- Industry reports and news articles
Disclaimer: This information is for educational purposes only and should not be considered investment advice.
About Evolent Health Inc
Exchange NYSE | Headquaters Arlington, VA, United States | ||
IPO Launch date 2015-06-05 | Co-Founder, CEO & Director Mr. Seth Barrie Blackley | ||
Sector Healthcare | Industry Health Information Services | Full time employees 4700 | Website https://www.evolent.com |
Full time employees 4700 | Website https://www.evolent.com |
Evolent Health, Inc., through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company provides platform for health plan administration and value-based business infrastructure. It offers administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. In addition, the company provides holistic total cost of care management. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.